Science news

Labatt Unveils Its First Zero-Emission Mobile Repair Truck

MONTREAL, July 18, 2024 /CNW/ - Labatt Breweries of Canada, a leading beverage company committed to sustainability, unveiled today its first zero-emission mobile repair...

Renalys Pharma announces first patient dosed in registrational Phase III clinical trial of sparsentan for IgA nephropathy in Japan

TOKYO, July 18, 2024 /PRNewswire/ -- Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys Pharma") announced today that the first person was dosed in its registrational...

Renovare to Showcase Innovative Organic Sustainable Waste Material Products at Inaugural 2024 SargaTech Conference

Renovare, the pioneer in sustainable organic waste materials for consumer goods such as footwear, is excited to showcase products in the inaugural 2024 SargaTech...

Sherwin-Williams Declares Dividend of $0.715 per Common Share

CLEVELAND, July 17, 2024 /PRNewswire/ -- The Board of Directors of The Sherwin-Williams Company (NYSE: SHW) today announced a regular quarterly dividend of $0.715...

USPTO Grants Acurx Pharmaceuticals New Patent for Ibezapolstat to Treat CDI While Reducing Recurrence of Infection and Improving Health of the Gut Microbiome

STATEN ISLAND, N.Y., July 17, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class...

Renalys Pharma Closes ¥6.0Bn Series A Financing to Advance Kidney Disease Treatments Across Asia

Financing Round Co-led by Catalys Pacific and SR One, Investment to Drive the Development of Sparsentan for IgA Nephropathy in Japan and Other Asian...

American Injectables Rolls Out Bold Rebrand

BROOKSVILLE, Fla., July 16, 2024 /PRNewswire/ -- American Injectables, a pharmaceutical CDMO, recently debuted their new brand with a website relaunch. Complete with new logo,...

Corneal Transplant Market to Reach an Estimated US$ 805.8 Million by 2034 with a CAGR of 5.6% from 2024 to 2034 | Exclusive Report...

The rising incidence of corneal diseases such as keratoconus, Fuchs' dystrophy, and corneal scarring from infections and injuries is driving demand for corneal transplants. WILMINGTON,...

Latest articles